InFocus Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

InFocus Therapeutics General Information

Description

Developer of therapeutics platform designed for the modulation of ribonucleic acid-based biological processes. The company's platform integrates computational modeling, throughput screening, and structure-guided chemistry to identify and optimize compounds that interact with ribonucleic acid across multiple disease areas, enabling biomedical researchers and drug-development organizations to access new therapeutic mechanisms and expand treatment possibilities beyond traditional protein-focused approaches.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Boston, MA
  • United States
+1 (903)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Boston, MA
  • United States
+1 (903)

InFocus Therapeutics Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InFocus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 10-Jun-2026 Completed Clinical Trials - Phase 1
8. Accelerator/Incubator Completed Clinical Trials - Phase 1
7. Angel (individual) 02-Jul-2025 Completed Clinical Trials - Phase 1
6. Accelerator/Incubator 02-Sep-2025 Completed Clinical Trials - Phase 1
5. Accelerator/Incubator 02-Jun-2025 Completed Clinical Trials - Phase 1
4. Grant 01-Jan-2025 Completed Clinical Trials - Phase 1
3. Accelerator/Incubator 10-Apr-2024 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator Completed Clinical Trials - Phase 1
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view InFocus Therapeutics’s complete valuation and funding history, request access »

InFocus Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InFocus Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
SparkLabs Group Venture Capital Minority
MassBio Accelerator/Incubator
Mass Innovation Network Accelerator/Incubator
Bpifrance Sovereign Wealth Fund
Berkeley SkyDeck Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

InFocus Therapeutics FAQs

  • When was InFocus Therapeutics founded?

    InFocus Therapeutics was founded in 2023.

  • Where is InFocus Therapeutics headquartered?

    InFocus Therapeutics is headquartered in Boston, MA.

  • What is the size of InFocus Therapeutics?

    InFocus Therapeutics has 10 total employees.

  • What industry is InFocus Therapeutics in?

    InFocus Therapeutics’s primary industry is Drug Discovery.

  • Is InFocus Therapeutics a private or public company?

    InFocus Therapeutics is a Private company.

  • What is InFocus Therapeutics’s current revenue?

    The current revenue for InFocus Therapeutics is .

  • How much funding has InFocus Therapeutics raised over time?

    InFocus Therapeutics has raised $1.2M.

  • Who are InFocus Therapeutics’s investors?

    SparkLabs Group, MassBio, Mass Innovation Network, Bpifrance, and Berkeley SkyDeck are 5 of 8 investors who have invested in InFocus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process